Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessPlatelets in COVID-19 disease: friend, foe, or both?
Immuno-thrombosis of COVID-19 results in the activation of platelets and coagulopathy. Antiplatelet therapy has been widely used in COVID-19 patients to prevent thrombotic events. However, recent analysis of c...
-
Article
Antithrombotic effect of novel N-methynicotinamide-like structure (C2507)
-
Article
Antithrombotic effects of pyridinium compounds present in coffee beans
-
Article
Editorial
-
Article
Editorial